Considering the role of CECR2 in modulating the immune response in the breast cancer tumor microenvironment and promoting metastasis, utilizing this agent to achieve an immune-responsive tumor microenvironment might be a promising approach to counter metastatic breast cancer with upregulated CECR2. Here, CECR2 is linked to neoplasm.